Pharmaceuticals News

ZUG, Switzerland, Nov. 29, 2024 (GLOBE NEWSWIRE) -- The attached notifications relate to the vesting of earnout shares and associated removal of restrictions on these ordinary shares. ...

KØBENHAVN, Danmark, 29. november 2024 – Bavarian Nordic A/S (OMX: BAVA) meddelte i dag, at selskabet har forhøjet sin aktiekapital med nominelt DKK 218.750 som følge af medarbejderes udnyttelse af...

COPENHAGEN, Denmark, November 29, 2024 – Bavarian Nordic A/S (OMX: BAVA) announced today that the Company's share capital has been increased by nominally DKK 218,750 as a consequence of employees’...

VANCOUVER, British Columbia, Nov. 28, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company” or “Rakovina Therapeutics”) a biopharmaceutical company committed to advancing...

MEDSIR, a leader in independent clinical research in oncology, strengthens its commitment to international collaboration and the exchange of scientific knowledge.Dr. Antonio Llombart-Cussac, Senior...

MEDSIR，作为肿瘤学独立临床研究的领军企业，进一步强化了其对于推动国际合作及科学知识交流的承诺。MEDSIR高级科学主管Antonio Llombart-Cussac博士发表了题为“HR+/HER2-乳腺癌的临床实践与未来管理” (Clinical Practice and Future Management of HR+/HER2- Breast Cancer)...

腫瘤學獨立臨床研究的領先機構 MEDSIR 加強與國際間合作及科學知識交流的承諾。MEDSIR 高級科學主管 Antonio Llombart-Cussac 博士發表題為「HR+/HER2- 型乳癌的臨床實踐及未來管理」 （"Clinical Practice and Future Management of HR+/HER2- Breast...

WINNIPEG, Manitoba, Nov. 28, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech”, “Kane” or the “Company”) today announces its third quarter 2024 financial results. ...

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Nov. 28, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM; HKEX:​13) today announces that following the contract renewal...

VANCOUVER, British Columbia, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company” or “Rakovina Therapeutics”) a biopharmaceutical company committed to advancing...